Announcements Trials
Browse Landscape

Phase

Phase 2 387Phase 1 115Phase 3 96Phase 1/2 62Phase 2/3 15Phase NA 14Phase 4 6Phase EARLY_PHASE1 5

Status

Unknown 9Completed 6Not yet recruiting 3Terminated 1Suspended 1Recruiting 1

Sponsor Class

INDUSTRY 4OTHER 1NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Colorectal Neoplasms 5Colonic Neoplasms 2Rectal Neoplasms 1Postoperative Complications 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Cisplatin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 4 × Completed × Oxaliplatin × Clear all
NCT01588990 2019-01-22

ASCENT

Hoffmann-La Roche

Phase 4 Completed
128 enrolled 20 charts
Gastrointestinal

Colorectal Neoplasms

NCT03084809 2017-03-21

Chemotherapy Combined With CIK Treating Colon Cancer

China Meitan General Hospital

Phase 4 Completed
46 enrolled
Gastrointestinal

Postoperative Complications, Colorectal Neoplasms

NCT02582970 2017-03-09

A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum

Hoffmann-La Roche

Phase 4 Completed
40 enrolled 12 charts
Gastrointestinal

Colorectal Neoplasms

NCT00577031 2015-08-18

OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.

Hoffmann-La Roche

Phase 4 Completed
205 enrolled 21 charts
Gastrointestinal

Colorectal Neoplasms

NCT00559676 2011-05-16

Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 4 Completed
200 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00263055 2009-09-15

MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV

Sanofi

Phase 4 Completed
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡